Drug Safety Information for SIMVASTATIN (Simvastatin)

FDA Safety-related Labeling Changes for ZOCOR (SIMVASTATIN) Rx Drug: Safety Information Link

Adverse Drug Reactions for SIMVASTATIN* (Simvastatin)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with SIMVASTATIN
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Nausea5726
2Dyspnoea5569
3Fatigue*4918
4Dizziness4883
5Drug ineffective4558
6Asthenia4350
7Myalgia*4321
8Pain*4252
9Diarrhoea4200
10Fall3703
11Rhabdomyolysis3690
12Myocardial infarction3632
13Drug interaction3600
14Headache3538
15Vomiting3524
16Renal failure acute3480
17Pain in extremity*3329
18Chest pain3135
19Arthralgia*3115
20Malaise2889

* This side effect also appears in "Top 10 Side Effects of SIMVASTATIN " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking SIMVASTATIN
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Blood cholesterol increased*48484
2Product used for unknown indication48324
3Hypercholesterolaemia*21718
4Hyperlipidaemia*14666
5Blood cholesterol*13880
6Blood cholesterol abnormal5199
7Dyslipidaemia3159
8Prophylaxis1467
9Coronary artery disease1321
10Hypertension*1231

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for SIMVASTATIN

Total Reports Filed with FDA: 487536


Number of FDA Adverse Event Reports by Patient Age for SIMVASTATIN

Total Reports Filed with FDA: 487536*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Simvastatin (Simvastatin, Zocor)

Charts are based on 487536 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and SIMVASTATIN Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.